Last reviewed · How we verify

NCT02372682

Shear Wave Sonoelastography in Pediatric Liver Fibrosis

Completed Results posted Last updated 12 September 2019
What this trial tests

trial testing Shear wave sonoelastography in Sonoelastography in 171 participants. Completed in 31 May 2018.

Timeline
11 May 2015
Primary endpoint
31 May 2018
31 May 2018

Quick facts

Lead sponsorSt. Louis University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment171
Start date11 May 2015
Primary completion31 May 2018
Estimated completion31 May 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

St. Louis University

Who can join

Under 18, any sex, with Sonoelastography or Elastography. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

2D-SWE Measurements' Capability of Predicting Stages of Fibrosis Based on METAVIR Scoring System Primary · 2 years

METAVIR score is a tool used to measure fibrosis as seen on liver biopsy and scored to describe liver disease progress and prognosis.

Sensitivity
GroupValue95% CI
Controls+METAVIR 0NA
METAVIR F196.9
METAVIR F295.2
METAVIR F31.00
Specificity
GroupValue95% CI
Controls+METAVIR 0NA
METAVIR F180.2
METAVIR F270.7
METAVIR F364.1
PPV
GroupValue95% CI
Controls+METAVIR 0NA
METAVIR F166.0
METAVIR F242.6
METAVIR F321.3
NPV
GroupValue95% CI
Controls+METAVIR 0NA
METAVIR F198.5
METAVIR F298.5
METAVIR F31.00
2D-SWE Measurements' Capability of Predicting Stages of Fibrosis Based on Ishak Scoring System Primary · 2 years

Ishak is a tool used to evaluate liver fibrosis via liver biopsy to report severity and prognosis of liver disease, specifically hepatitis.

Sensitivity
GroupValue95% CI
Control + Ishak 0NA
Ishak 193.8
Ishak 295.8
Ishak 395.2
Ishak 4100.0
Specificity
GroupValue95% CI
Control + Ishak 0NA
Ishak 179.0
Ishak 273.0
Ishak 370.7
Ishak 462.3
PPV
GroupValue95% CI
Control + Ishak 0NA
Ishak 163.8
Ishak 248.9
Ishak 342.6
Ishak 414.9
NPV
GroupValue95% CI
Control + Ishak 0NA
Ishak 196.9
Ishak 298.5
Ishak 398.5
Ishak 4100.0

Sponsor's own description

Reliable methods of evaluating liver fibrosis using noninvasive techniques in the pediatric population are limited and inconclusive. Liver biopsy remains the gold standard; however, it requires sedation in pediatric patients, has a risk of hemorrhage, and provides unreliable results secondary to sampling error. Sonoelastography is a new method of evaluating liver disease that eliminates these pitfalls. There are 3 types of quantitative sonoelastography currently in use. Transient elastography is a non-imaging based technique used in adults to measure liver fibrosis in which a mechanical vibrator creates a low-frequency wave causing shear stress in the liver at a fixed depth. This technique does not work in small livers and, therefore, is not appropriate for pediatric patients. Acoustic Radiation Force Impulse Imaging (ARFI) and Shear Wave Imaging (SWE) use real-time ultrasonography and administer focused high-intensity, short-duration pulses to produce shear waves in the liver tissue. ARFI calculates the degree of tissue displacement and creates an elastogram or measurement of the stiffness of the sampled liver tissue without corresponding images. It is limited since only a small sample or region of interest (ROI) can be obtained, and it is unable to provide a corresponding elasticity map of the tissue. SWE is the newest elastography technique. It measures tiny displacements of tissue in a larger ROI with corresponding ultrasound images which provides a side by side image of the liver and color-coded elasticity map of the sampled tissue. Advantages include a larger ROI and simultaneous viewing of the selected region of interest which provides better anatomic detail with a corresponding color map of the tissue elasticity which may result in more accurate scoring of the stage of fibrosis. There are a few studies of ARFI in the pediatric population. Studies using SWE for evaluation of liver fibrosis are also few, and, all but one in adults. However, these studies have shown it to be an accurate method for liver fibrosis staging. Use of SWE in assessing liver fibrosis in pediatric patients may represent an accurate noninvasive alternative to liver biopsy in evaluating liver fibrosis as well as avoid the use of sedation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other St. Louis University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02372682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing